Suppr超能文献

β2微球蛋白检测在检测急性移植排斥反应中的原理及应用

Rationale and application of beta-2-microglobulin measurements to detect acute transplant rejection.

作者信息

Roxe D M, Siddiqui F, Santhanam S, del Greco F, Wolf J

出版信息

Nephron. 1981;27(4-5):260-4. doi: 10.1159/000182064.

Abstract

Serum and urinary concentrations of beta 2-microglobulin were measured for the first 21 days after renal transplantation to aid in diagnosis of acute rejection. Criteria developed after study of 15 patients were applied to the entire group of 31 consecutive cases. 29 instances meeting our criteria were identified in 651 days at risk and were associated with a mean maximal increase of serum creatinine of 74.8%. beta 2-Microglobulin methods may make possible detection of what is now subclinical rejection. beta 2-Microglobulin methods, however, are an adjunct to, not a replacement for classical methods for detecting acute rejection.

摘要

在肾移植后的前21天测量血清和尿液中β2-微球蛋白的浓度,以辅助急性排斥反应的诊断。对15例患者进行研究后制定的标准应用于连续31例的整个研究组。在651天的观察期内,共识别出29例符合我们标准的病例,这些病例与血清肌酐平均最大增幅74.8%相关。β2-微球蛋白检测方法可能使目前亚临床排斥反应的检测成为可能。然而,β2-微球蛋白检测方法只是检测急性排斥反应的经典方法的辅助手段,而非替代方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验